Colin John Meyer - 28 Feb 2023 Form 4 Insider Report for REATA PHARMACEUTICALS INC

Role: Chief Innovation Officer
Signature: /s/ Tracy Herson, attorney-in-fact
Issuer symbol: N/A
Transactions as of: 28 Feb 2023
Net transactions value: $0
Form type: 4
Filing time: 01 Mar 2023, 15:18:33 UTC
Previous filing: 04 Jan 2023
Next filing: 06 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RETA	Class A common stock	Award	$0	+15,000	+20%	$0.000000	90,513	28 Feb 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RETA	Employee Stock Option (right-to-buy)	Award	$0	+30,000		$0.000000	30,000	28 Feb 2023	Class A common stock	30,000	$27.32	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares represent Restricted Stock Units granted with performance criteria (PSUs). On January 2, 2021, the reporting person was granted 15,000 PSUs. On February 28, 2023, based on the satisfaction of certain performance criteria, the PSUs vested as to 6,563 shares and is set to vest one quarter of 11,250 shares on March 31, 2023; June 30, 2023, and September 30, 2023, subject to continued service through each vesting date.
F2	On January 3, 2022, the reporting person was granted an option to purchase 30,000 shares of Class A common stock. On February 28, 2023 based on the satisfaction of certain performance criteria, the option vested as to 13,125 shares and is set to vest 5,625 shares on March 31, 2023; June 30, 2023, and September 30, 2023, subject to continued service through each vesting date.

Content

The shares represent Restricted Stock Units granted with performance criteria (PSUs). On January 2, 2021, the reporting person was granted 15,000 PSUs. On February 28, 2023, based on the satisfaction of certain performance criteria, the PSUs vested as to 6,563 shares and is set to vest one quarter of 11,250 shares on March 31, 2023; June 30, 2023, and September 30, 2023, subject to continued service through each vesting date.

On January 3, 2022, the reporting person was granted an option to purchase 30,000 shares of Class A common stock. On February 28, 2023 based on the satisfaction of certain performance criteria, the option vested as to 13,125 shares and is set to vest 5,625 shares on March 31, 2023; June 30, 2023, and September 30, 2023, subject to continued service through each vesting date.